13.01.2017
Drägerwerk AG & Co. KGaA DE0005550602
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger improves earnings despite decline in net sales
DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results
Drägerwerk AG & Co. KGaA: Dräger improves earnings despite decline in net
sales
13-Jan-2017 / 15:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Dräger improves earnings despite decline in net
sales
Drägerwerk announces preliminary, unaudited figures for fiscal year 2016.
Net sales declined by roughly 3.3 percent (net of currency effects: -1.5
percent) to approximately EUR 2.52 billion (2015: EUR 2.61 billion). As a
result, net sales growth in 2016 fell short of Dräger's latest forecast
range. Earnings improved significantly in spite of the decline in net
sales. This improvement was the result of a stable gross margin (2015: 44.9
percent) and a significant reduction in the cost base. The EBIT margin is
likely to stand between 5.0 and 5.5 percent (2015: 2.6 percent). For 2016
order intake rose by 0.4 percent (net of currency effects: 2.2 percent).
Net sales fell short of expectations in the Africa, Asia, and Australia
region, particularly in the Middle East, and in many European countries in
2016. By contrast, business in Germany and the Americas region developed
positively. This development largely continued in the fourth quarter, too.
Dräger will publish full, audited results for fiscal year 2016 and a
forecast for fiscal year 2017 on Wednesday, March 8, 2017.
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com
Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]
Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]
Disclaimer
This ad hoc report contains statements on the future development of Dräger
Group. These forward-looking statements are based on the current
expectations, presumptions, and forecasts of the Executive Board as well as
the information available to date. They were compiled to the best of the
company's knowledge. Dräger does not provide any warranty nor assume any
responsibility for the future developments and results described above.
These are dependent on a number of factors. They entail various risks and
contingencies outside of the company's influence and are based on
assumptions which could prove to be incorrect. Dräger does not assume any
responsibility for updating the forward-looking statements contained in
this report. This does not infringe any legal stipulations on the
adjustment of forecasts. Please go to Investor Relations / Financial
Calendar at www.draeger.com for information on all important financial
dates.
---------------------------------------------------------------------------
13-Jan-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000
555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067
Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Hamburg, Hanover, Munich; Regulated Unofficial
Market in Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service
---------------------------------------------------------------------------
536335 13-Jan-2017 CET/CEST
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Drägerwerk AG & Co. KGaA ISIN: DE0005550602 können Sie bei EQS abrufen
Medtech , 555060 , DRW8 , XETR:DRW8